All lobbying filings

CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Lobbying for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $196,425.00 income · posted Jul 17, 2025

Official filing document

Bills named in this filing 6

HR 4273
Over-the-Counter Monograph Drug User Fee Amendments
S 355
FDA Modernization Act 3.0
HR 2821
FDA Modernization Act 3.0
HR 3686
SAFE Sunscreen Standards Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 1219
Oral Health Products Inclusion Act

Lobbying activity 5

Health Issues

H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness

Pharmacy

- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling

Consumer Issues/Safety/Products

- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.

Taxation/Internal Revenue Code

- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)

Manufacturing

- Pharmaceutical Tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.